UVEAL MELANOMA

UVEAL MELANOMA was reported 56 times

UVEAL MELANOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] 5 0.0083
1 Histone Deacetylase Inhibitor [EPC] 1 0.0003
2 Carbonic Anhydrase Inhibitor [EPC] 3 0.0001
3 Nuclear Export Inhibitor [EPC] 1 0.0001
4 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
5 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
6 Interleukin-12 Antagonist [EPC] 4 0.0000
7 Interleukin-23 Antagonist [EPC] 4 0.0000
8 Purine Antimetabolite [EPC] 3 0.0000
9 Vascular Endothelial Growth Factor Inhibitor [EPC] 5 0.0000
10 Alkylating Drug [EPC] 6 0.0000
11 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
12 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
13 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
14 Kinase Inhibitor [EPC] 9 0.0000
15 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
16 beta-Adrenergic Blocker [EPC] 4 0.0000
17 Retinoid [EPC] 3 0.0000
18 Factor Xa Inhibitor [EPC] 3 0.0000
19 Prostaglandin Analog [EPC] 1 0.0000
20 Proton Pump Inhibitor [EPC] 5 0.0000
21 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
22 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
23 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
24 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
25 Thalidomide Analog [EPC] 2 0.0000
26 Platinum-based Drug [EPC] 1 0.0000
27 Corticosteroid [EPC] 4 0.0000
28 GLP-1 Receptor Agonist [EPC] 1 0.0000
29 Insulin Analog [EPC] 1 0.0000
30 Atypical Antipsychotic [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000